Difference between revisions of "Combined Nuclear Medicine Biomarker Committee Call Summaries"
Jump to navigation
Jump to search
m |
m |
||
| Line 1: | Line 1: | ||
| + | ==2016== | ||
| + | *[[Media:02 26 2016 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|02.26.2016 QIBA Nuclear Medicine Leadership Call Summary]] | ||
| + | |||
| + | |||
| + | |||
| + | ==2015== | ||
*[[Media:10 23 2015 QIBA Nuclear Medicine Leadership Call Summary-FINAL-ep.pdf|10.23.2015 QIBA Nuclear Medicine Leadership Call Summary]] | *[[Media:10 23 2015 QIBA Nuclear Medicine Leadership Call Summary-FINAL-ep.pdf|10.23.2015 QIBA Nuclear Medicine Leadership Call Summary]] | ||
*[[Media:08 28 2015 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|08.28.2015 QIBA Nuclear Medicine Leadership Call Summary]] | *[[Media:08 28 2015 QIBA Nuclear Medicine Leadership Call Summary-DRAFT.pdf|08.28.2015 QIBA Nuclear Medicine Leadership Call Summary]] | ||
Revision as of 16:32, 23 March 2016
2016